Pure Global
NCT05080894

Virtual Reality Rehabilitation for Patients With Anterior Cruciate Ligament Reconstruction

Early Domestic Rehabilitation Using Virtual Reality for Patients With Anterior Cruciate Ligament Reconstruction: a Randomized Controlled Trial
Institut d'Investigacions Biomèdiques August Pi i Sunyer·ClinicalTrials.gov·device·Device trialRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Knee Injuries
Drug/Device/Intervention
Virtual reality
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Location
Barcelona, Spain
Timeline & enrollment
Phase
N/A
Start date
Oct 01, 2021
End date
Mar 15, 2023
Enrollment
44 participants
Primary outcome

The International Knee Documentation Committee (IKDC) Subjective Knee Form,The International Knee Documentation Committee (IKDC) Subjective Knee Form,The International Knee Documentation Committee (IKDC) Subjective Knee Form,The International Knee Documentation Committee (IKDC) Subjective Knee Form

Summary

The purpose of this study is to ascertain whether 4 weeks of daily virtual-reality-based
 rehabilitation at home improves disability in the early stages of recovery from anterior
 cruciate ligament reconstruction surgery compared with standard care.

ICD-10 classifications
Injuries to the knee and lower legSprain and strain of other and unspecified parts of kneeOther spontaneous disruption of ligament(s) of kneeCrushing injury of kneeInjury to multiple structures of knee
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05080894
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05080894 through Pure Global AI's free database. This phase not specified trial is sponsored by Institut d'Investigacions Biomèdiques August Pi i Sunyer and is currently Recruiting. The study focuses on Knee Injuries. Target enrollment is 44 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.